Genmab, J&J Ink $1.1B CA Pact; XBiotech Poised for Big Time Boom - Aug. 30, 2012

Having trouble viewing this email? View in Browser.

Thursday, August 30, 2012  |   |   |   |  FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS A Hybrid Conference and Internet Event Sponsored by Latin American Ethics and Compliance Network Cosponsored by Pharmaceutical Compliance Forum Media Partners: Life Science Compliance and RX Compliance Report October 2 - 4, 2012 Hilton Sao Paulo Morumbi Sao Paulo, Brazil Please click here for more information.   •  Genmab, Inc. (GEN.CO), Johnson & Johnson (JNJ) Ink $1.1 Billion CA Pact More... •  XBiotech USA, Inc. Poised for Big Time Boom More... •  Aerpio Completes $27 Million Series A Financing More... •  Charles River Laboratories (Massachusetts) Buys Accugenix Inc. for $17 Million More... •  Novartis AG (NVS) to Seek Lung Treatment Launch in Europe, Japan After Phase III Study Goals Were Met More... •  FDA Warns of Possible Cataract Link With Vertex Pharmaceuticals (MA) (VRTX)'s Kalydeco More... •  Johnson & Johnson (JNJ) Prostate Cancer Drug Gets FDA Priority Review Status More... •  FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Copycat of Amgen (AMGN)'s Neupogen More... More Top News JAX® In Vivo Pharmacology Services Rely on our unmatched expertise in efficacy studies to accelerate your drug discovery research. Our in vivo pharmacology testing services are fast, flexible, and supported by our 80-year history in mouse-based research. We provide comprehensive, data-driven efficacy testing in a wide range of therapeutic areas: • Oncology • Inflammatory and autoimmune disease • Metabolic disorders • Neuromuscular and neurodegenerative disorders To date, we have performed in vivo studies in over 100 mouse strains, We work closely with you to ensure that any custom protocols are executed to your exact specifications, and have documented success in implementing conventional protocols and adapting the latest procedures from the literature. Please click here for more information. Life Science Map Spotlights Bay Area Companies BioSpace.com launched the seventeenth edition of the Biotech Bay® Hotbed campaign today, highlighting leading bioscience companies across the San Francisco Bay Area and Northern California. Click here to find the 2012-2013 Biotech Bay Hotbed homepage. Click here to find the 2012-2013 Biotech Bay campaign map. •  Patent Threats, and the Cheap Cost of R&D More... •  Low-Calorie Diets Don't Help Lifespan, National Institute on Aging Study More... •  Does Loss of Daily Rhythms Cause Obesity? University of Aberdeen Study More... •  Chocolate May Protect the Brain From Stroke, Karolinska Institute Study More... •  Washington State University Researchers Discover Mechanism Leading From Trichomoniasis to Prostate Cancer More... •  In New Gene Disorder, B12 Can't Get to Cells, McGill University Study More... •  National Institute of Allergy And Infectious Diseases (NIAID) Scientists Map First Steps in Flu Antibody Development More... •  New Cancer Drug Has 10x the Punch, University of Missouri Study More...   More Featured News The 6th Annual Pain Therapeutics October 3-4, 2012 San Francisco, CA Event Website ARROWHEAD'S ANNUAL PAIN THERAPEUTICS SUMMIT is the US's premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA's REMS program and a plethora of other topics. Please click here for more information. • Genetown (Cambridge, Massachusetts) Vertex Associate Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The AD will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Genetown (Cambridge, Massachusetts) Vertex Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The Director will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Pharm Country (Summit, New Jersey) Celgene Scientist II Will be responsible for well-defined and controlled experiments being mindful of translational relevance. Responsible for experimental design, interpretation of results and making scientific presentations to global project teams and senior management. • Biotech Beach (Santa Monica, California) Astellas Pharma US QC Microbiologist Supervisor Supervise staff, product testing and Environmental Monitoring data within the QC Microbiology department in support of clinical manufacturing. The role will act as a technical expert within the organization with extensive knowledge related to aseptic procedure and compendial testing. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Quality Systems Program Manager Provide a regional resource to lead TGRD US functional teams in the identification and mitigation of systemic issues which may compromise the compliance of Takeda's drug development operations. The person in this position will work with PDD Global Quality Assurance and TGRD US project teams in the quality investigation, deviation and waiver process including root cause analysis, remediation, tracking and documentation. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 • Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure. •Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market. • Understand the basic PFC manufacturing processes and the raw materials used in their production. Click Here for More Information. Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury, New Jersey 08512 U.S.A. Phone: 609-662-2000 Fax: 609-662-2807 Amicus Therapeutics is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company is developing novel, first-in-class, small molecules called pharmacological chaperones, to treat human genetic diseases, including lysosomal storage diseases. More Company Profiles FREE Subscription to Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products in a way that no other publication can to key decision-makers. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.